Page last updated: 2024-11-08

triiodothyronine and Bowel Diseases, Inflammatory

triiodothyronine has been researched along with Bowel Diseases, Inflammatory in 5 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Bertani, L3
Tricò, D3
Pugliese, D2
Privitera, G1
Linsalata, G1
Zanzi, F1
Gloria Mumolo, M1
Barberio, B1
Monzani, F1
Marchi, S1
Guidi, L1
Blandizzi, C2
Armuzzi, A1
Costa, F2
Carbery, I1
Selinger, CP1
Paschou, SA1
Palioura, E1
Kothonas, F1
Myroforidis, A1
Loi, V1
Poulou, A1
Goumas, K1
Effraimidis, G1
Vryonidou, A1

Other Studies

5 other studies available for triiodothyronine and Bowel Diseases, Inflammatory

ArticleYear
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue.
    Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:5

    Topics: Biomarkers; Humans; Inflammatory Bowel Diseases; Thyroxine; Triiodothyronine

2022
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
    Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:2

    Topics: Aged; Biological Therapy; Humans; Inflammatory Bowel Diseases; Middle Aged; Thyroxine; Treatment Out

2021
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
    Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:2

    Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat

2021
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?
    Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:2

    Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat

2021
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
    Endocrine journal, 2018, Nov-29, Volume: 65, Issue:11

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal A

2018